4.6 Article

Shp-2 knockdown prevents l-dopa-induced dyskinesia in a rat model of Parkinson's disease

Related references

Note: Only part of the references are listed.
Review Oncology

The clinical development of MEK inhibitors

Yujie Zhao et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2014)

Article Medicine, Research & Experimental

PSD-95 expression controls L-DOPA dyskinesia through dopamine D1 receptor trafficking

Gregory Porras et al.

JOURNAL OF CLINICAL INVESTIGATION (2012)

Review Clinical Neurology

Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation

Mahmoud M. Iravani et al.

JOURNAL OF NEURAL TRANSMISSION (2011)

Article Biochemistry & Molecular Biology

The tyrosine phosphatase Shp-2 interacts with the dopamine D1 receptor and triggers D1-mediated Erk signaling in striatal neurons

Chiara Fiorentini et al.

JOURNAL OF NEUROCHEMISTRY (2011)

Article Pharmacology & Pharmacy

Targeting Protein Tyrosine Phosphatases for Anticancer Drug Discovery

Latanya M. Scott et al.

CURRENT PHARMACEUTICAL DESIGN (2010)

Review Chemistry, Medicinal

Protein tyrosine phosphatases as drug targets: strategies and challenges of inhibitor development

Alastair J. Barr

FUTURE MEDICINAL CHEMISTRY (2010)

Article Multidisciplinary Sciences

Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry

Alexxai V. Kravitz et al.

NATURE (2010)

Article Multidisciplinary Sciences

Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors

Helen S. Bateup et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Cell Biology

Lentiviral Overexpression of GRK6 Alleviates L-Dopa-Induced Dyskinesia in Experimental Parkinson's Disease

Mohamed R. Ahmed et al.

SCIENCE TRANSLATIONAL MEDICINE (2010)

Review Anatomy & Morphology

Basal ganglia circuits underlying the pathophysiology of levodopa-induced dyskinesia

Pedro Barroso-Chinea et al.

FRONTIERS IN NEUROANATOMY (2010)

Article Pharmacology & Pharmacy

Controls of Tonic and Phasic Dopamine Transmission in the Dorsal and Ventral Striatum

Lifen Zhang et al.

MOLECULAR PHARMACOLOGY (2009)

Review Clinical Neurology

The scientific and clinical basis for the treatment of Parkinson disease (2009)

C. Warren Olanow et al.

NEUROLOGY (2009)

Editorial Material Pharmacology & Pharmacy

Dopaminergic signaling in dendritic spines

Wei-Dong Yao et al.

BIOCHEMICAL PHARMACOLOGY (2008)

Article Clinical Neurology

Pharmacokinetics and pharmacodynamics of levodopa

John G. Nutt

MOVEMENT DISORDERS (2008)

Article Neurosciences

Comparison of dopamine D1 and D5 receptor knockout mice for cocaine locomotor sensitization

Rose-Marie Karlsson et al.

PSYCHOPHARMACOLOGY (2008)

Review Clinical Neurology

Levodopa-induced dyskinesias

Giovanni Fabbrini et al.

MOVEMENT DISORDERS (2007)

Article Multidisciplinary Sciences

Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum

E Valjent et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Review Neurosciences

Desensitization of G protein-coupled receptors and neuronal functions

RR Gainetdinov et al.

ANNUAL REVIEW OF NEUROSCIENCE (2004)

Review Biochemistry & Molecular Biology

The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling

BG Neel et al.

TRENDS IN BIOCHEMICAL SCIENCES (2003)

Article Biochemistry & Molecular Biology

SKF83959 selectively regulates phosphatidylinositol-linked D1 dopamine receptors in rat brain

LQ Jin et al.

JOURNAL OF NEUROCHEMISTRY (2003)